v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]            
Revenue $ 61,809 $ 160,785 $ 61,809 $ 234,737 $ 210,279 $ 197,136
Operating expenses:            
Direct cost of revenue 11,025 119,221 11,025 150,063 80,354 58,292
Professional fees 873,865 455,552 1,417,905 984,625 2,269,756 1,153,731
Salary expenses 902,106 683,197 1,817,746 1,567,238 2,887,309 915,210
Research and development 1,371,470 244,686 2,589,766 636,190 1,681,899 687,734
Stock-based compensation 676,242 194,657 1,392,674 562,375 898,444 1,833,292
Depreciation and amortization 210,361 26,715 420,722 (186,216) 43,871 591,458
Other general and administrative expenses 618,498 349,496 1,009,070 645,068 1,170,029 757,022
Total operating expenses 4,663,567 2,073,524 8,658,908 4,359,343 9,031,662 5,996,739
Total operating loss (4,601,758) (1,912,739) (8,597,099) (4,124,606) (8,821,383) (5,799,603)
Other income (expense)            
Interest and accretion expenses (530,226) (4,189) (829,770) (4,189) (126,024) (45,450)
Change in fair value of contingent liabilities (1,792,000) 278,000 (3,622,000) 278,000 (1,387,000)
Loss on debt extinguishment         (663,522)
Total other income (expense) (2,322,226) 273,811 (4,451,770) 273,811 (2,176,546) (45,450)
Net loss $ (6,923,984) $ (1,638,928) $ (13,048,869) $ (3,850,795) $ (10,997,929) $ (5,845,053)
Loss per share – basic and diluted (in Dollars per share) $ (0.68) $ (0.18) $ (1.28) $ (0.43) $ (1.22) $ (0.89)
Weighted average number of shares of common stock outstanding – basic and diluted (in Shares) 10,207,212 8,982,212 10,182,185 8,982,057 9,010,403 6,593,496